Big Payout Candidates
This carefully selected group of companies is flush with cash and primed to reward investors. Each stock has been handpicked by our analysts for its potential to deliver exceptional returns through special dividends or substantial buybacks above their regular shareholder payouts.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Apple, Inc.
AAPL
Current price
$230.56
Its immense free cash flow, generated from a powerful ecosystem of hardware, software, and services, has built one of the largest corporate cash piles...
Its immense free cash flow, generated from a powerful ecosystem of hardware, software, and services, has built one of the largest corporate cash piles in history.
Microsoft Corporation
MSFT
Current price
$509.77
Dominance in cloud computing and enterprise software creates a torrent of predictable cash, enabling significant and sustained capital returns to its ...
Dominance in cloud computing and enterprise software creates a torrent of predictable cash, enabling significant and sustained capital returns to its shareholders.
Alphabet Inc (Google)
GOOGL
Current price
$201.57
The company's fortress balance sheet is fueled by its digital advertising empire, providing overwhelming financial capacity for shareholder-friendly a...
The company's fortress balance sheet is fueled by its digital advertising empire, providing overwhelming financial capacity for shareholder-friendly actions.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
These companies have amassed enormous cash reserves far beyond their operational needs. Their financial strength positions them as prime candidates for rewarding shareholders through special dividends or significant stock buybacks, potentially creating substantial value in ways regular dividends cannot match.
What You Need to Know
This collection spans diverse sectors including tech giants, consumer staples, and healthcare leaders. Each company features a fortress-like balance sheet with minimal debt, providing both defensive stability during economic uncertainty and flexibility to reward shareholders generously.
Why These Stocks
We've specifically targeted mature, profitable businesses with proven track records of conservative financial management and impressive free cash flow generation. These industry leaders have demonstrated the capacity to generate excess cash, making them ideal candidates for extraordinary capital returns.
Group Performance Snapshot
Stocks Rated Buy by Analysts
12 of 14 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 4.3% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
Cash Hoards Ready to Be Released
These companies are sitting on mountains of cash that could soon flow to shareholders. When companies decide to reward investors, stock prices often respond dramatically.
Built to Weather Any Storm
Strong balance sheets provide exceptional stability during economic uncertainty. These cash-rich companies offer both defensive protection and the exciting potential for significant shareholder rewards.
The Smart Money Is Watching
Professional investors closely monitor cash-rich companies for special dividend announcements or major buyback programs. Getting in before these catalysts can position you for substantial returns.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.